Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 901 AL 915

A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease

Vijverberg E, de Haan W, Scheijbeler E, Hamby ME, Catalano S, Scheltens P, Grundman M, Caggiano AO.

J Prev Alzheimers Dis. 2024;11(6):1809-1817. doi: 10.14283/jpad.2024.154.

The emerging field of non-invasive brain stimulation in Alzheimer's disease

Koch G, Altomare D, Benussi A, Bréchet L, Casula EP, Dodich A, Pievani M, Santarnecchi E, Frisoni GB.

Brain. 2024 Dec 3;147(12):4003-4016. doi: 10.1093/brain/awae292.

The new perspective of Alzheimer's Disease Research: Mechanism and therapeutic strategy of neuronal senescence

Niu Q, Li D, Zhang J, Piao Z, Xu B, Xi Y, Mohamed Kamal NNSN, Lim V, Li P, Yin Y.

Ageing Res Rev. 2024 Dec;102:102593. doi: 10.1016/j.arr.2024.102593. Epub 2024 Nov 19.

Research progress on the association of insulin resistance with type 2 diabetes mellitus and Alzheimer's disease

Zheng M, Wang C, Hu M, Li Q, Li J, Quan S, Zhang X, Gu L.

Metab Brain Dis. 2024 Nov 21;40(1):35. doi: 10.1007/s11011-024-01472-y.

Animal models of Alzheimer's disease: Current strategies and new directions

Wang Q, Zhu BT, Lei P.

Zool Res. 2024 Nov 18;45(6):1385-1407. doi: 10.24272/j.issn.2095-8137.2024.274.

A randomized clinical trial evaluating Hydralazine's efficacy in early-stage Alzheimer's disease: The EHSAN Study

Mirzaei M, Ahmadi N, Bagheri Fahraji B, Ardekani AM, Rahimdel A, Soltani MH, Ardekani SMY, Bidaki R, Kasnavie FH, Dastjerdi G, Aboutorabi M, Mirzaei H.

Sci Rep. 2024 Nov 21;14(1):28837. doi: 10.1038/s41598-024-79616-4.

Progress of research and application of non-pharmacologic intervention in Alzheimer's disease

Tang M, Guo JJ, Guo RX, Xu SJ, Lou Q, Hu QX, Li WY, Yu JB, Yao Q, Wang QW.

J Alzheimers Dis. 2024 Nov;102(2):275-294. doi: 10.1177/13872877241289396. Epub 2024 Oct 29.

Mechanism of Metal Complexes in Alzheimer's Disease

Liu Y, Ma J, Zhang Q, Wang Y, Sun Q.

Int J Mol Sci. 2024 Nov 5;25(22):11873. doi: 10.3390/ijms252211873.

New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer's Disease Treatment

Angelova VT, Stoyanov BP, Simeonova R.

Molecules. 2024 Nov 11;29(22):5314. doi: 10.3390/molecules29225314.

Molecular and Cellular Foundations of Aging of the Brain: Anti-aging Strategies in Alzheimer's Disease

Dziewa M, Złotek M, Herbet M, Piątkowska-Chmiel I.

Cell Mol Neurobiol. 2024 Nov 28;44(1):80. doi: 10.1007/s10571-024-01514-0.

Monitoring drug Efficacy through Multi-Omics Research initiative in Alzheimer's Disease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and metabolomic signatures in Filipino patients with Alzheimer's disease

Climacosa FMM, Anlacan VMM, Gordovez FJA, Reyes JCB, Tabios IKB, Manalo RVM, Cruz JMC, Asis JLB, Razal RB, Abaca MJM, Dacasin AB, Espiritu APN, Gapaz NCLL, Lee Yu MHL.

BMJ Open. 2024 Nov 27;14(11):e078660. doi: 10.1136/bmjopen-2023-078660.

The role of the FKBP51-Hsp90 complex in Alzheimer's disease: An emerging new drug target

Jeanne X, Török Z, Vigh L, Prodromou C.

Cell Stress Chaperones. 2024 Dec;29(6):792-804. doi: 10.1016/j.cstres.2024.11.006. Epub 2024 Nov 29.

Treatment of Alzheimer Disease

Geldmacher DS.

Continuum (Minneap Minn). 2024 Dec 1;30(6):1823-1844. doi: 10.1212/CON.0000000000001503.

A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease

Yang H, Byun MS, Ha NY, Yang J, Park SY, Park JE, Yi D, Chang YT, Jung WS, Kim JY, Kim J, Lee DY, Bae H.

Biomed Pharmacother. 2024 Dec;181:117721. doi: 10.1016/j.biopha.2024.117721. Epub 2024 Dec 2.

Polyphenols and Their Biogenic Nano-Formulations Targeting BACE1 as Anti-Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease

Elawad MA, Ayaz M, Mosa OF, Usman A, Hamdoon AAE, Almawash S, Salim LHM, Ahmed A, Elkhalifa MEM.

Mol Nutr Food Res. 2024 Dec;68(24):e2400525. doi: 10.1002/mnfr.202400525. Epub 2024 Dec 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias